California Appeals Court Reverses Summary Judgment In Diabetes Drug Case

(November 7, 2018, 10:42 AM EST) -- LOS ANGELES — A California state appeals court on Nov. 6 reversed summary judgment for three drug makers in the state’s coordinated incretin mimetic diabetes drug litigation, saying the trial court...
To view the full article, register now.